DoreenOnipedeJacksonMD

PubMed

• 33 citations
  Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
  Tommy A. Brown, Elizabeth A. Mittendorf, Diane F. Hale, John W. Myers, Kaitlin M. Peace, Doreen O. Jackson, Julia M. Greene, Timothy J. Vreeland, G. Travis Clifton, Al...> ;Breast Cancer Research and Treatment. 2020 Apr 22
• 18 citations
  Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients.
  Tommy A. Brown, Kevin Byrd, Timothy J. Vreeland, Guy T. Clifton, Doreen O. Jackson, Diane F. Hale, Garth S. Herbert, John W. Myers, Julia M. Greene, John S. Berry, Jon...> ;Cancer Medicine. 2019 Aug 1
• 7 citations
  Effects of HLA status and HER2 status on outcomes in breast cancer patients at risk for recurrence – Implications for vaccine trial design
  Doreen O. Jackson, Francois A. Trappey, G. Travis Clifton, Timothy J. Vreeland, Kaitlin M. Peace, Diane F. Hale, Jennifer K. Litton, James L. Murray, Sonia A. Perez, M...> ;Clinical Immunology. 2018 Oct 1
• 7 citations
  Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune response.
  Timothy J. Vreeland, Jennifer K. Litton, Na Qiao, Anne V. Philips, Gheath Alatrash, Diane F. Hale, Doreen O. Jackson, Kaitlin M. Peace, Julia M. Greene, Guy T. Clifton...> ;Clinical Immunology. 2018 Mar 21
• 17 citations
  Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors.
  Garth S. Herbert, Timothy J. Vreeland, Guy T. Clifton, Julia M. Greene, Doreen O. Jackson, Mark O. Hardin, Diane F. Hale, John S. Berry, Pauline Nichol, Sook Yin, Xian...> ;Vaccine. 2018 May 31
• 9 citations
  Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine.
  Mark O. Hardin, Timothy J. Vreeland, Guy T. Clifton, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Doreen O. Jackson, John E Berry, Pauline Nichols, Sook Yin, Xian...> ;Immunotherapy. 2018 Apr 1
• 2 citations
  Routine Pre-Treatment MRI for Breast Cancer in a Single-Payer Medical Center: Effects on Surgical Choices, Timing and Outcomes.
  Timothy J. Vreeland, John S. Berry, Erika J Schneble, Doreen O. Jackson, Garth S. Herbert, Diane F. Hale, Jonathon M Martin, Madeline Flores, Adam R Pattyn, Kai W. Hat...> ;Journal of Cancer. 2017 Jul 23
• 26 citations
  Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions.
  John S. Berry, Timothy J. Vreeland, Alfred F. Trappey, Diane F. Hale, Kaitlin M. Peace, Joshua A. Tyler, Avery Walker, Ramon Brown, Garth S. Herbert, Fia Yi, Doreen O....> ;Expert Review of Clinical Immunology. 2017 Mar 4
• 8 citations
  Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients
  Doreen O. Jackson, Kevin Byrd, Timothy J. Vreeland, Diane F. Hale, Garth S. Herbert, Julia M. Greene, Erika J Schneble, John S. Berry, Alfred F. Trappey, Guy T. Clifto...> ;Oncotarget. 2017 Feb 28
• 5 citations
  Evaluation of attenuated tumor antigens and the implications for peptide-based cancer vaccine development
  John S. Berry, Timothy J. Vreeland, D F Hale, Doreen O. Jackson, Alfred F. Trappey, Julia M. Greene, Mark O. Hardin, Garth S. Herbert, Guy T. Clifton, George E. Peoples> ;Journal of Cancer. 2017 May 11
• 24 citations
  Gaining ground on a cure through synergy: combining checkpoint inhibitors with cancer vaccines.
  Timothy J. Vreeland, Guy T. Clifton, Garth S. Herbert, Diane F. Hale, Doreen O. Jackson, John S. Berry, George E. Peoples> ;Expert Review of Clinical Immunology. 2016 Jun 28
• 26 citations
  A phase I/IIa clinical trial in stage IV melanoma of an autologous tumor–dendritic cell fusion (dendritoma) vaccine with low dose interleukin-2
  Julia M. Greene, Erika J Schneble, Doreen O. Jackson, Diane F. Hale, Timothy J. Vreeland, Madeline Flores, Jonathan Martin, Garth S. Herbert, Mark O. Hardin, Xianzhong...> ;Cancer Immunology, Immunotherapy. 2016 Feb 19
• Join now to see all